ES2134388T3 - Combinaciones de antigenos del virus de la hepatitis c (hcv) para su uso en inmunoensayos para anticuerpos anti-hcv. - Google Patents

Combinaciones de antigenos del virus de la hepatitis c (hcv) para su uso en inmunoensayos para anticuerpos anti-hcv.

Info

Publication number
ES2134388T3
ES2134388T3 ES95114016T ES95114016T ES2134388T3 ES 2134388 T3 ES2134388 T3 ES 2134388T3 ES 95114016 T ES95114016 T ES 95114016T ES 95114016 T ES95114016 T ES 95114016T ES 2134388 T3 ES2134388 T3 ES 2134388T3
Authority
ES
Spain
Prior art keywords
hcv
combinations
immuno
hepatitis
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95114016T
Other languages
English (en)
Other versions
ES2134388T5 (es
Inventor
Michael Houghton
Qui-Lim Choo
George Kuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24005897&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2134388(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of ES2134388T3 publication Critical patent/ES2134388T3/es
Application granted granted Critical
Publication of ES2134388T5 publication Critical patent/ES2134388T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pinball Game Machines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Thermistors And Varistors (AREA)

Abstract

SE PRESENTAN COMBINACIONES DE ANTIGENOS HCV QUE TIENEN UNA GAMA MAS AMPLIA DE REACTIVIDAD INMUNOLOGICA QUE CUALQUIER ANTIGENO HCV SIMPLE. LAS COMBINACIONES CONSTAN DE UN ANTIGENO DEL DOMINANTE C DE LA POLIPROTEINA DEL HCV, Y UN ANTIGENO ADICIONAL DEL HCV DEL DOMINANTE S, OPCIONALMENTE CON UN ANTIGENO ADICIONAL PARA CUALQUIERA DE LOS DOMINANTES NS3, NS4 O NS5, Y TIENEN LA FORMA DE UNA PROTEINA DE FUSION, UNA MEZCLA FISICA SIMPLE, O DE LOS ANTIGENOS INDIVIDUALES COMUNMENTE UNIDOS A UNA MATRIZ SOLIDA.
ES95114016T 1990-04-04 1991-04-03 Combinaciones de antigenos del virus de la hepatitis c (hcv) para su uso en inmunoensayos para anticuerpos anti-hcv. Expired - Lifetime ES2134388T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50435290A 1990-04-04 1990-04-04
US504352 1990-04-04

Publications (2)

Publication Number Publication Date
ES2134388T3 true ES2134388T3 (es) 1999-10-01
ES2134388T5 ES2134388T5 (es) 2008-12-01

Family

ID=24005897

Family Applications (2)

Application Number Title Priority Date Filing Date
ES95114016T Expired - Lifetime ES2134388T5 (es) 1990-04-04 1991-04-03 Combinaciones de antigenos del virus de la hepatitis c (hcv) para su uso en inmunoensayos para anticuerpos anti-hcv.
ES91302910T Expired - Lifetime ES2088465T3 (es) 1990-04-04 1991-04-03 Combinaciones de antigenos del virus c de la hepatitis (hcv) para uso en inmunoensayos para anticuerpos anti-hcv.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES91302910T Expired - Lifetime ES2088465T3 (es) 1990-04-04 1991-04-03 Combinaciones de antigenos del virus c de la hepatitis (hcv) para uso en inmunoensayos para anticuerpos anti-hcv.

Country Status (25)

Country Link
EP (2) EP0693687B2 (es)
JP (1) JP2733138B2 (es)
KR (1) KR100206150B1 (es)
AT (2) ATE182684T1 (es)
BG (1) BG61291B1 (es)
BR (1) BR9106309A (es)
CY (1) CY1881A (es)
DE (2) DE69131488T2 (es)
DK (2) DK0693687T4 (es)
ES (2) ES2134388T5 (es)
FI (1) FI106317B (es)
GB (1) GB2257784B (es)
GR (2) GR3020964T3 (es)
HU (1) HU217025B (es)
IE (1) IE911105A1 (es)
IL (2) IL170719A (es)
LT (1) LT3808B (es)
LV (2) LV10344A (es)
MY (1) MY107499A (es)
NO (1) NO310241B1 (es)
PL (1) PL172133B1 (es)
RO (1) RO109916B1 (es)
RU (1) RU2130969C1 (es)
UA (1) UA41266C2 (es)
WO (1) WO1991015771A1 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001261B (el) 1989-12-18 1993-06-30 Wellcome Found Ιϊκός παράγων.
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US6194140B1 (en) 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
DE69132332T2 (de) * 1990-04-06 2000-11-30 Genelabs Technologies, Inc. Hepatitis c-virus-epitope
CA2049679C (en) * 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
SK286106B6 (sk) * 1990-11-08 2008-03-05 Novartis Vaccines & Diagnostics, Inc. Spôsob vykonávania imunodiagnostickej skúšky na detekciu protilátky proti vírusu hepatitídy C
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
DK0644202T3 (da) * 1990-12-14 1997-09-15 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
US5910404A (en) 1990-12-14 1999-06-08 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
US6007982A (en) * 1990-12-14 1999-12-28 Innogenetics N.V. Synthetic antigens for the detection of antibodies to hepatitis C virus
DE4041304A1 (de) * 1990-12-21 1992-06-25 Mikrogen Molekularbiol Entw Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
EP0573624A4 (en) * 1991-11-07 1997-09-17 Baxter Diagnostics Inc Epitope mapping ot the c33c region of hcv
EP0610436B9 (en) * 1991-11-21 2003-03-26 Common Services Agency Hepatitis-c virus testing
DK0625204T3 (da) * 1992-02-04 2002-07-15 Chiron Corp Terapeutiske midler mod hepatitis
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
EP0593291A3 (en) * 1992-10-16 1995-03-15 Evernew Biotech Inc Non-structural protein of the hepatitis C virus, as well as diagnostic procedure and test kit.
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
JP2778886B2 (ja) * 1992-10-16 1998-07-23 エバーニュー バイオテック インコーポレイティド Ｃ型肝炎ウィルスのコア抗原タンパク質及びそれを用いての診断方法及びキット
WO1994013164A1 (en) 1992-12-10 1994-06-23 Nike International Ltd. Bonding of rubber to plastic in footwear
KR100312534B1 (ko) 1993-04-28 2002-05-13 성재갑 씨(c)형간염및비(b)형간염동시측정면역블롯검정키트및면역블롯검정법
DK0698216T4 (da) * 1993-05-10 2009-06-15 Novartis Vaccines & Diagnostic Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri
DE4428705A1 (de) 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
JPH0862219A (ja) * 1994-08-19 1996-03-08 Dainabotsuto Kk 還元型抗原に対する抗体アッセイ試薬及びそれを使用した測定方法
JP3665371B2 (ja) * 1994-08-31 2005-06-29 株式会社先端生命科学研究所 Ｃ型肝炎ウイルス感染又はグループ判定のためのエピトープキメラ抗原ペプチド、その製法、及びそれを使用する感染又はグループ判定法
CA2172305A1 (en) * 1995-03-30 1996-10-01 Muneo Aoyama Multiple antigenic peptide comprising at least two hepatitis c virus-associated peptides
AU5924396A (en) * 1995-05-22 1996-12-11 Bionova Corporation Compositions and methods for the diagnosis of, and vaccinati on against, hepatitis c virus (hcv)
FR2734639B1 (fr) * 1995-05-26 1997-10-03 Parteurop Methode de pronostic de l'evolution d'une infection par le virus de l'hepatite c, et necessaire pour sa mise en oeuvre
FR2737209B1 (fr) 1995-07-25 1997-09-19 Bio Merieux Peptide capable d'etre reconnu par des anticorps reconnaissant l'antigene c33 du virus de l'hepatite c
US6127116A (en) 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
JP3715027B2 (ja) 1996-05-07 2005-11-09 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬
US7049428B1 (en) 1998-03-04 2006-05-23 Washington University HCV variants
US7338759B1 (en) 1997-03-04 2008-03-04 Washington University HCV variants
DE69837155T2 (de) * 1997-09-22 2007-06-21 Novartis Vaccines and Diagnostics, Inc., Emeryville Verfahren zum nachweiss von antikörpern in einer probe
AU6098900A (en) * 1999-07-15 2001-02-05 Bayer Corporation The use of specific antibody titers to predict hepatic failure in people infected with hepatitis c virus
AU1236801A (en) 1999-10-27 2001-05-08 Chiron Corporation Activation of hcv-specific t cells
RU2179726C2 (ru) * 1999-11-17 2002-02-20 Государственный научный центр вирусологии и биотехнологии "Вектор" Способ изготовления контрольных панелей сывороток для контроля качества диагностики гепатита в
US6986892B1 (en) 1999-11-24 2006-01-17 Chiron Corporation Immunogenic Hepatitis C virus non-structural polypeptides
WO2001038360A2 (en) * 1999-11-24 2001-05-31 Chiron Corporation Novel hcv non-structural polypeptide
SI1354204T2 (sl) 2000-06-15 2010-09-30 Novartis Vaccines & Diagnostic Hcv antigen antitelo kombinacijska analiza
US7491808B2 (en) 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
RU2172489C1 (ru) * 2000-07-26 2001-08-20 Тверская государственная медицинская академия Способ диагностики множественной миеломы
JP5175417B2 (ja) 2000-08-17 2013-04-03 トリペップ アクチ ボラゲット リバビリンを含むワクチンおよびその使用方法
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
FR2839722A1 (fr) 2002-05-17 2003-11-21 Bio Merieux Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
RU2226694C2 (ru) * 2002-05-30 2004-04-10 Научно-исследовательский институт детских инфекций Способ дифференциальной диагностики вирусного гепатита с
ES2312806T3 (es) 2002-09-09 2009-03-01 Novartis Vaccines And Diagnostics, Inc. Ensayo de vhc.
WO2005123952A2 (en) 2004-06-09 2005-12-29 Pathogen Removal And Diagnostic Technologies Inc. Particles embedded ina porous substrate for removing target analyte from a sample
RU2262704C1 (ru) * 2004-10-06 2005-10-20 Общество с ограниченной ответственностью Научно-производственное объединение "Диагностические системы" Набор антигенов для определения антител к вирусу гепатита c "дс-hcv-антигены"
JP2005274584A (ja) * 2005-05-25 2005-10-06 Sysmex Corp Ｃ型肝炎ウイルス感染症診断薬の製造方法
JP4005093B2 (ja) * 2005-05-25 2007-11-07 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬および抗ｈｃｖ抗体検出方法
CA2618429A1 (en) 2005-05-25 2007-03-22 Tripep Ab A hepatitis c virus non-structural ns3/4a fusion gene
RU2327170C2 (ru) * 2006-02-27 2008-06-20 Закрытое акционерное общество "ДиТест" Способ комплексной диагностики вирусного гепатита в, вирусного гепатита с, вич-инфекции и сифилиса
MX2008011361A (es) * 2006-03-09 2008-09-15 Transgene Sa Proteina de fusion no-estructural del virus de hepatitis c.
EP1978365B1 (en) 2007-03-16 2010-08-25 Sysmex Corporation Reagent kit and method for measuring HCV antibody
US20090214593A1 (en) 2007-08-16 2009-08-27 Tripep Ab Immunogen platform
US8071561B2 (en) 2007-08-16 2011-12-06 Chrontech Pharma Ab Immunogen platform
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
ES2828713T3 (es) 2014-10-29 2021-05-27 Abbott Lab Ensayos de detección de anticuerpos anti-VHC objeto usando péptidos de captura NS3
JP2018124277A (ja) * 2017-02-02 2018-08-09 三洋化成工業株式会社 粒子含有組成物、免疫測定用試薬、免疫測定方法及び粒子の保存方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US456637A (en) 1891-07-28 Fence
US390599A (en) 1888-10-02 Tool for weaver s use
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4870008A (en) * 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
CA1341423C (en) † 1984-10-31 2003-03-04 Paul A. Luciw Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
US4751180A (en) * 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
JPH02500880A (ja) * 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
KR0185373B1 (ko) † 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
GR1001261B (el) * 1989-12-18 1993-06-30 Wellcome Found Ιϊκός παράγων.
CA2032907C (en) † 1989-12-22 2002-05-14 Richard R. Lesniewski Hepatitis c assay

Also Published As

Publication number Publication date
LTIP1747A (en) 1995-07-25
ATE139343T1 (de) 1996-06-15
NO310241B1 (no) 2001-06-11
EP0693687B1 (en) 1999-07-28
GB2257784B (en) 1995-01-04
NO923839D0 (no) 1992-10-01
GR3020964T3 (en) 1996-12-31
AU639560B2 (en) 1993-07-29
HU217025B (hu) 1999-11-29
FI924349L (fi) 1992-09-28
DE69120138T2 (de) 1996-11-14
EP0450931A1 (en) 1991-10-09
HU9203146D0 (en) 1992-12-28
RU2130969C1 (ru) 1999-05-27
CY1881A (en) 1996-04-05
GB2257784A (en) 1993-01-20
ES2134388T5 (es) 2008-12-01
ES2088465T3 (es) 1996-08-16
GR3031361T3 (en) 2000-01-31
DK0450931T3 (da) 1996-07-01
PL172133B1 (pl) 1997-08-29
LV10344B (en) 1996-02-20
IL97741A0 (en) 1992-06-21
EP0693687B2 (en) 2008-06-04
LV10344A (en) 1994-10-20
IE911105A1 (en) 1991-10-09
JP2733138B2 (ja) 1998-03-30
AU7651091A (en) 1991-10-30
DE69131488D1 (de) 1999-09-02
BR9106309A (pt) 1993-04-20
FI924349A0 (fi) 1992-09-28
EP0450931B1 (en) 1996-06-12
BG96943A (bg) 1993-12-24
KR100206150B1 (ko) 1999-07-01
DK0693687T3 (da) 1999-11-29
EP0693687A1 (en) 1996-01-24
DE69131488T2 (de) 1999-11-18
UA41266C2 (uk) 2001-09-17
MY107499A (en) 1995-12-30
LT3808B (en) 1996-03-25
RO109916B1 (ro) 1995-07-28
NO923839L (no) 1992-11-19
DK0693687T4 (da) 2008-09-22
HUT62706A (en) 1993-05-28
WO1991015771A1 (en) 1991-10-17
IL170719A (en) 2011-04-28
BG61291B1 (en) 1997-04-30
GB9220480D0 (en) 1992-11-25
DE69120138D1 (de) 1996-07-18
FI106317B (fi) 2001-01-15
ATE182684T1 (de) 1999-08-15
JPH05508219A (ja) 1993-11-18

Similar Documents

Publication Publication Date Title
ES2134388T3 (es) Combinaciones de antigenos del virus de la hepatitis c (hcv) para su uso en inmunoensayos para anticuerpos anti-hcv.
BRPI0111682B8 (pt) suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
ES2171414T3 (es) Inmunoensayos para anticuerpos anti-hcv utilizando antigenos con epitopos conformacionales.
ES2065863T1 (es) Ensayo del virus de la hepatitis c.
NO870412L (no) Peptider.
ATE410693T1 (de) Hcv-test
ES2118129T3 (es) Anticuerpos monoclonales contra las regiones de cubierta putativas del virus vhc y procedimientos de utilizacion de estos.
DE3377401D1 (de) Non-a, non-b hepatitis antigen
ES2126598T3 (es) Anticuerpos monoclonales que se fijan sobre las proteinas ns5 supuestas del virus de la hepatitis c, y procedimientos de utilizacion de estos anticuerpos.
MY100476A (en) Supported viral antigen and preparation and use thereof
PT97247A (pt) Processo de preparacao de combinacoes de antigenios do virus da hepapite c (hcv) para uso em imunoensaios para anticorpos anti-hcv
ATE86120T1 (de) Hepatitis nanb-viraler stoff, antigen und immunologisches reagenz.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 693687

Country of ref document: ES